Skip to main content

Table 1 Demographic and clinical characteristics of cohort participants according to year of first visit

From: Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004–2015: a persisting problem

Variables

2004–2006

2007–2009

2010–2012

2013–2015

Total

\({\chi }^{2}\)

N (%)

N (%)

N (%)

N (%)

N (%)

p-value

Age

< 0.001

 Median (IQR)

37 (29.0–43.0)

35 (28.0–42.8)

34 (28.0–43.0)

33 (27.0–42.0)

35 (28.0–43.0)

< 0.001

 18–24

77 (9.6)

125 (11.8)

147 (13.8)

138 (14.6)

4687 (12.6)

 

 25–34

273 (33.9)

394 (37.1)

388 (36.3)

372 (39.5)

1427 (36.8)

 

 35–49

365 (45.3)

437 (41.1)

402 (37.6)

323 (34.3)

1527 (39.4)

 

 50 or more

91 (11.3)

106 (10.0)

132 (12.3)

109 (11.6)

438 (11.3)

 

Ethnicity/skin color

< 0.0001

 White

499 (61.9)

483 (45.5)

430 (40.2)

344 (36.5)

1756 (45.3)

 

 Black

122 (15.1)

202 (19.0)

262 (24.5)

189 (20.1)

775 (20.0)

 

 Brown

184 (22.8)

369 (34.7)

352 (32.9)

394 (41.8)

1299 (33.5)

 

 Missing

1 (0.1)

8 (0.8)

25 (2.3)

15 (1.6)

49 (1.3)

 

Years of education

< 0.0001

 ≤ 5

213 (26.4)

294 (27.7)

330 (30.9)

227 (24.1)

1064 (27.4)

 

 6–9

192 (23.8)

226 (21.3)

182 (17.0)

112 (11.9)

712 (18.4)

 

 ≥ 10

397 (49.3)

539 (50.8)

537 (50.2)

584 (62.0)

2057 (53.0)

 

 Missing

4 (0.5)

3 (0.3)

20 (1.9)

19 (2.0)

46 (1.2)

 

Gender/sexual preference

< 0.0001

 Cis-W

240 (29.8)

346 (32.6)

322 (30.1)

213 (22.6)

1121 (28.9)

 

 Trans-W

5 (0.6)

34 (3.2)

29 (2.7)

102 (10.8)

170 (4.4)

 

 MSM

293 (36.4)

362 (34.1)

384 (45.9)

364 (38.6)

1403 (36.3)

 

 MSW

211 (26.2)

264 (24.9)

226 (21.1)

124 (13.2)

825 (21.3)

 

 Missing

57 (7.1)

56 (5.3)

108 (10.1)

139 (14.8)

360 (9.3

 

ART-naïve before first visit

< 0.0001

 No

230 (28.5)

165 (15.5)

216 (20.2)

248 (26.3)

859 (22.1)

 

 Yes

576 (71.5)

897 (84.5)

853 (79.8)

694 (73.7)

3020 (77.9)

 

CD4 count (cells/µL)1

0.31

 ≤ 50

97 (12.0)

144 (13.6)

153 (14.3)

120 (12.7)

514 (13.3)

 

 51–200

164 (20.3)

217 (20.4)

213 (19.9)

177 (18.8)

771 (19.9)

 

 201–350

155 (19.2)

184 (17.3)

180 (16.8)

166 (17.6)

685 (17.7)

 

 > 350

328 (40.7)

439 (41.3)

461 (43.1)

430 (45.6)

1658 (42.7)

 

 Missing

62 (7.7)

78 (7.3)

62 (5.8)

49 (5.2)

251 (6.5)

 

Viral load (copies/mL)1

 < 0.0001

 < 400

112 (13.9)

173 (16.3)

222 (20.8)

209 (22.2)

716 (18.5)

 

 400–999

25 (3.1)

22 (2.1)

43 (4.0)

24 (2.5)

114 (2.9)

 

 ≥ 1.000

508 (63.0)

693 (65.3)

712 (66.6)

641 (68.0)

2554 (65.8)

 

 Missing

161 (20.0)

174 (16.4)

92 (8.6)

68 (7.2)

495 (12.8)

 

Prior AIDS-defining illness2

< 0.0001

 No

641 (79.5)

763 (71.8)

758 (70.9)

712 (75.6)

2874 (74.1)

 

 Yes

165 (20.5)

299 (28.2)

311 (29.1)

230 (24.4)

1005 (25.9)

 

Total

806

1062

1069

942

3879

 
  1. INI cohort, 2004–2015 (N = 3879)
  2. IQR Interquartile range
  3. p-value regarding the Brown-Mood test for median difference
  4. 1CD4 count and viral load were measured at first visit
  5. 2Prior AIDS-defining illness was defined using a window of 180 days before up to 30 days after first visit